Supernus Pharmaceuticals, Inc. (SUPN) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

All right, good afternoon and welcome to the SuperNIST Pharmaceuticals Third Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. Instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the conference over to Peter Bozzo of ICR Healthcare investor relations representative for Sopranos Pharmaceuticals. You may now begin. Thank you, Raven. Good afternoon, everyone, and thank you for joining us today for Sopranos Pharmaceuticals' third quarter 2025 financial results conference call. Today, after the close of the market, the company issued a press release announcing the results. On the call with me today are Sopranos' chief executive officer, Jack Attar, and financial officer, Tim Deck. These calls are being made available via the investor relations section of the company's website at www.ir.sopernus.com. During the course of this call, management may make certain forward-looking statements regarding the future event and the company's future performance. These forward-looking statements reflect Sopernus' current perspective on the existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those noted in the risk factor section of the company's latest SEC filings. After results may differ materially from those projected in these forward-looking statements. For the benefit of those who may be listening to the replay, this call is being held and recorded on November 4th, 2025. Since then, the company may have made additional announcements related to the topics discussed. Please reference the company's most recent press ...